The Lawyer Global Litigation Top 50 report is the only ranking of international law firms by litigation and arbitration revenue and is essential reading for anyone seeking to benchmark their litigation and dispute resolution practices...
This year, The Lawyer’s annual ranking of the largest UK law firms by turnover is available as an interactive, digital benchmarking tool. For the first time this will allow you to manipulate each data set against the metrics of your choice.
Morgan Cole has chosen health and social care as its latest target industry group as it continues to overhaul its structure
The group, which has a core of 19 fee-earners in Cardiff and the Thames Valley, won target industry group status after proving its business case to Morgan Cole's board. It will be led by highly-rated partner Graham Miles. Miles said: "The modern health and social care industry is a very dynamic one, requiring a combination of skills which we've developed over many years." Health follows energy, insurance and technology to win the special status, which signals a long-term commitment to the designated industry in terms of resourcing.
"The health and social care industry is a very dynamic one, requiring skills that we've developed over many years" Graham Miles, Morgan Cole
The group focuses on organisations concerned with health and social care in both the public and private sectors. Clients include 29 NHS trusts in England and Wales, 12 health authorities, two primary care trusts, the UK Central Council for Nursing, Midwifery and Health Visiting as well as a number of private sector providers. Particular areas of expertise include mental health law, for which it boasts well-known consultant Richard Jones, community care law, professional conduct work, employment, technology and a substantial regulatory practice. In the regulatory field, Morgan Cole has been the exclusive legal adviser to the Human Fertilisation & Embryology Authority since 1996. Since then, it has handled a number of high-profile and difficult matters, including judicial review proceedings brought by Diane Blood and giving evidence before a select committee of the House of Commons on the scope of regulatory provisions concerning human cloning following the birth of Dolly the Sheep. Morgan Cole recently successfully defended a judicial review application relating to restrictions on the number of embryos that can be transferred to a woman in a single treatment cycle.